Healthcare Innovations for Canadians
Valeo Pharma is committed to provide healthcare professionals and patients with innovative therapeutic solutions to improve quality of life.
Valeo pharma's HespercoTM capsules at the core of montreal heart institute's hesperidin coronavirus clinical trial
HespercoTM capsules contain 500mg of Valeo's unique hesperidin formulation and are available in bottles of 60 capsules. Hesperidin is a flavonoid with powerful antioxidant properties that help support the immune system.
For more information, please visit www.hesperco.com
VALEO PHARMA COMPLETES NEGOTIATIONS WITH PAN-CANAD...
March 31, 2021
VALEO PHARMA REPORTS ITS FIRST QUARTER 2021 RESULT...
About Valeo Pharma
Driven by our experienced management team with in-depth knowledge of the Canadian market conditions and long-standing relationships with key industry leaders and healthcare professionals, our solid business model provides the required resources to successfully introduce specialty pharmaceutical products to Canada.